ABCL - Health Care Select Sector SPDR ETF: An Arsenal Of Therapies To Conquer COVID

• In addition to vaccines, it is now the turn of antibodies treatment to play a role in fighting COVID.
• There are also the diagnostics developers that still have an important stake in enabling recovery in intercontinental travel through rapid testing.
• Political challenges remain but, it is unlikely that there will be drastic policy reviews until Democrats have the power to carry out sweeping changes.
• XLV provides exposure to three vaccine and antibody treatment plays who have already made it to approval stage with Johnson & Johnson closely following.
• There should be an upside based on an update by JP Morgan that major pharma is trading at 35% discount.

For further details see: